Clinical trials
Phase 1 Anemia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 6 |
| 2015 | 5 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Terminated | 7 |
| Recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 9 |
| Akebia Therapeutics | 4 |
| National Cancer Institute (NCI) | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| AMAG Pharmaceuticals, Inc. | 1 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| Akros Pharma Inc. | 1 |
| Apellis Pharmaceuticals, Inc. | 1 |
| Bayer | 1 |
| Baylor College of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 49 |
| Renal Insufficiency, Chronic | 8 |
| Hematologic Diseases | 4 |
| Myelodysplastic Syndromes | 4 |
| Anemia, Iron-Deficiency | 3 |
| Anemia, Sickle Cell | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Multiple Myeloma | 3 |
| Renal Insufficiency | 3 |
| Thrombocytopenia | 3 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.